Steven J. Soldin, PhD, FACB, FCACB
Director, Endocrinology
Dr. Soldin brings 34 years of clinical chemistry expertise to the Endocrinology Department at NMS Labs. As the Clinical Director of Endocrinology at NMS Labs, Dr. Soldin provides direct oversight of the analytical development and implementation of testing as well as ensuring clinical utility of testing. He is a thought leader in the use of mass spectrometry for endocrinology laboratory testing, and his research interests include the expanding role of tandem mass spectrometry in clinical laboratories, particularly for the measurement of steroids and thyroid hormones. Dr. Soldin’s world-renowned reputation in clinical endocrinology testing complements NMS Labs mission to provide superior quality of testing and serve as market leaders to the health care industry.
Most recently, Dr. Soldin was a tenured Professor of Pediatrics and Pathology at the George Washington University School of Medicine. He is currently a Professor in the Departments of Medicine and Pharmacology at Georgetown University. Having authored 224 papers in peer-reviewed journals, he is considered to be one of the foremost experts in clinical pharmacology, therapeutic drug monitoring and endocrinology. For 12 years he served as a consultant to the College of American Pathologist Therapeutic Drug Monitoring / Endocrinology Proficiency Testing Program and his laboratory at Georgetown is currently a reference laboratory to the NY State PT program. Dr. Soldin holds 16 patents. In addition to his teaching responsibilities, Dr. Soldin is the Director of the Mass Spectrometry Core Laboratory at Georgetown University. He is certified in Clinical Chemistry by the American Board of Clinical Chemistry and the Canadian Academy of Clinical Biochemistry.
Dr. Soldin has won many awards that include the prestigious Pippenger Award of the International Association of Therapeutic Drug Monitoring/ Clinical Toxicology and the Al Dubin Award from the National Academy of Clinical Biochemistry. He is a past President of the American Board of Clinical Chemistry, the National Academy of Clinical Biochemistry and the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
<<Back
|